A nationwide shortage of Adderall is making it harder for some parents to help their children manage the symptoms of attention-deficit/hyperactivity disorder (ADHD).

A national shortage of Adderall has left patients who rely on the pills for attention-deficit/hyperactivity disorder scrambling to find alternative treatments and uncertain whether they will be able to refill their medication. The Food and Drug Administration announced the shortage last week, saying that one of the largest producers is experiencing “intermittent manufacturing delays” and…

Around the Practice: Management of Adult with Attention Deficit/Hyperactivity Disorder (ADHD) – Episode 14. Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to deal with other comorbidities when treating an adult with ADHD.

KEY POINTS: A recent study showed ADHD is associated with a higher risk of cardiovascular disease compared with controls. Though the danger is high for both men and women, males and young adults are at somewhat higher risk. The most common risks are for cardiac arrest, stroke, and peripheral vascular disease/arteriosclerosis. The cognitive and physical…

Scientists have demonstrated a new way to study conditions like autism spectrum disorder, ADHD, and schizophrenia. The approach involves transplanting a cluster of living human brain cells from a dish in the lab to the brain of a newborn rat, a team from Stanford University reports in the journal Nature.

A recent study investigated the effect of psychostimulants modafinil, atomoxetine, and guanfacine on the differentiation of mesenchymal stem cells to osteoblasts and on their cell functions, including migration. Researchers determined that the 3 medications commonly used to treat attention-deficit/hyperactivity disorder (ADHD) negatively affect hMSC differentiation to bone-forming osteoblasts and cell migration through different intracellular pathways.(1)

Comorbid SUD and ADHD is associated with more severe illness. What do we understand about these comorbid conditions and what do we still need to learn?

Oct. 13 (UPI) — Diagnosing attention-deficit/hyperactivity disorder, or ADHD, in adolescents doesn’t improve their self-reported quality of life compared with teens with similar behaviors but no diagnosis. And it may significantly increase their risk of self-harm.

Prescriptions for controlled stimulants among adolescents and young adults have increased significantly in the US since 2008. In a new research letter assessing the recent trends of controlled medication prescriptions for young Americans, a team of Boston investigators observed a substantial increase in stimulants among adolescents aged 13-18 years old and young adults aged 19-25…

Oct 12 (Reuters) – The U.S. Food and Drug Administration said on Wednesday there was a shortage of Adderall, a treatment for attention deficit hyperactivity disorder, following intermittent manufacturing delays at Teva Pharmaceutical Industries Ltd (TEVA.TA).

Researchers at Oregon Health & Science University estimate the true percentage of people with Attention-Deficit/Hyperactivity Disorder, or ADHD, in the United States is approximately 3.5% of the population — substantially lower than many common estimates. The study, published this month in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), also found…

Mental illness can be difficult to diagnose (via Annals of General Psychiatry). Unlike physical illnesses, such as diabetes and high blood pressure, there are no blood tests or medical instruments to pinpoint many psychiatric disorders. So, it’s important to consult a practitioner who has the right knowledge and expertise.